Tumor receptor imaging

DA Mankoff, JM Link, HM Linden… - Journal of nuclear …, 2008 - Soc Nuclear Med
Tumor receptors play an important role in carcinogenesis and tumor growth and have been
some of the earliest targets for tumor-specific therapy, for example, the estrogen receptor in …

[HTML][HTML] Receptor targeted nuclear imaging of breast cancer

SU Dalm, JF Verzijlbergen, M De Jong - International Journal of …, 2017 - mdpi.com
Receptor targeted nuclear imaging directed against molecular markers overexpressed on
breast cancer (BC) cells offers a sensitive and specific method for BC imaging. Currently, a …

Imaging diagnostic and therapeutic targets: steroid receptors in breast cancer

AM Fowler, AS Clark… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Estrogen receptor alpha (ERα) and progesterone receptor (PR) are important steroid
hormone receptor biomarkers used to determine prognosis and to predict benefit from …

Designing steroid receptor-based radiotracers to image breast and prostate tumors.

JA Katzenellenbogen - Journal of nuclear medicine: official …, 1995 - europepmc.org
Imaging of breast or prostate cancers based on their content of steroid receptors poses a
major challenge in the design of radiotracers. Receptors for steroid hormones are proteins …

Receptor imaging: competitive or complementary to antibody imaging?

SJ Goldsmith - Seminars in nuclear medicine, 1997 - Elsevier
Both radiolabeled ligands to specific receptors on cell surfaces and radiolabeled antibodies
to specific cell surface epitopes provide new opportunities to scintigraphically identify …

Recent advances in imaging steroid hormone receptors in breast cancer

M Kumar, K Salem, AJ Tevaarwerk… - Journal of Nuclear …, 2020 - Soc Nuclear Med
Estrogen receptor (ER) and progesterone receptor (PR) are important prognostic and
predictive biomarkers in breast cancer. PET using ER-and PR-specific radioligands enables …

Somatostatin receptor imaging

DJ Kwekkeboom, EP Krenning - Seminars in nuclear medicine, 2002 - Elsevier
[111In-DTPA0] octreotide is a radiopharmaceutical with a great potential for the visualization
of somatostatin receptor-positive tumors. The overall sensitivity of Somatostatin Receptor …

Peptide receptor imaging and therapy

D Kwekkeboom, EP Krenning… - Journal of Nuclear …, 2000 - Soc Nuclear Med
This article reviews the results of somatostatin receptor imaging (SRI) in patients with
somatostatin receptor–positive neuroendocrine tumors, such as pituitary tumors, endocrine …

[PDF][PDF] Receptor-binding radiopharmaceuticals for imaging breast tumors: estrogen-receptor interactions and selectivity of tissue uptake of halogenated estrogen …

JA Katzenellenbogen, KE Carlson… - Journal of Nuclear …, 1980 - Soc Nuclear Med
MATERIALS AND METHODS Materials were obtained from the following sources: tris (hy
droxymethyl) aminomethane (Tris),* charcoal Norit A,* Dextran grade C,@ p-bis [2-(5-phenyl …

Imaging of neuroendocrine tumours with gamma-emitting radiopharmaceuticals

E Bombardieri, A Coliva, M Maccauro… - … Quarterly Journal of …, 2010 - search.proquest.com
Nuclear medicine can image some tumors by means of receptor specific
radiopharmaceuticals, and offers the possibility to characterize cancer through the detection …